Quick Answer
HCW Biologics Inc. reported Long Term Debt of $0.00 for the year ending 2025.
- HCW Biologics Inc. showed a decrease of -100.0% in Long Term Debt from 2024 to 2025.
- This data is from HCW Biologics Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $6.45 million | Q1 2023: $6.39 million | Q2 2023: $6.36 million | Q3 2023: $6.33 million | Q1 2024: $8.27 million | Q2 2024: $9.90 million | Q3 2024: $6.46 million | Q1 2025: $7.71 million | Q2 2025: $367.2 thousand | Q3 2025: $0.00.
- Historical annual values: Fiscal year 2025: $0.00 | Fiscal year 2024: $7.38 million | Fiscal year 2023: $6.30 million | Fiscal year 2022: $6.41 million | Fiscal year 2021: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: